Cabozantinib and Vandetanib in medullary thyroid carcinoma: mitochondrial function and its potential as a therapeutic target towards novel strategies to design anti-CSCs drugs. Issue 10 (3rd October 2018)

Record Type:: Journal Article
Title:: Cabozantinib and Vandetanib in medullary thyroid carcinoma: mitochondrial function and its potential as a therapeutic target towards novel strategies to design anti-CSCs drugs. Issue 10 (3rd October 2018)
Main Title:: Cabozantinib and Vandetanib in medullary thyroid carcinoma: mitochondrial function and its potential as a therapeutic target towards novel strategies to design anti-CSCs drugs
Authors:: Tampaki, Ekaterini Christina
Tampakis, Athanasios
Droeser, Raoul
Patsouris, Efstratios
Kouraklis, Gregory
Abstract:
Is Part Of:: Cancer biology & therapy. Volume 19:Issue 10(2018)
Journal:: Cancer biology & therapy
Issue:: Volume 19:Issue 10(2018)
Issue Display:: Volume 19, Issue 10 (2018)
Year:: 2018
Volume:: 19
Issue:: 10
Issue Sort Value:: 2018-0019-0010-0000
Page Start:: 847
Page End:: 849
Publication Date:: 2018-10-03
Subjects:: 616.99406
Journal URLs:: http://www.tandfonline.com/ ↗
DOI:: 10.1080/15384047.2018.1433495 ↗
Languages:: English
ISSNs:: 1538-4047
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 3046.456700
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 7970.xml